This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 2002-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 834,453 Years Active: 2002-2006
Title: Marie Helena Caparon: Innovator in Hematopoiesis Research
Introduction
Marie Helena Caparon is a distinguished inventor based in Chesterfield, MO (US). She has made significant contributions to the field of hematopoiesis through her innovative research and patented inventions. With a total of 2 patents, her work focuses on the development of fusion proteins and compositions that enhance hematopoiesis.
Latest Patents
One of her latest patents is titled "IL-3 variant hematopoiesis fusion protein." This invention relates to fusion molecules composed of human interleukin-3 (hIL-3) variant or mutant proteins, functionally joined to a second colony stimulating factor (CSF), cytokine, lymphokine, interleukin, or IL-3 variant. The hIL-3 variants contain amino acid substitutions and may also have amino acid deletions at both the N- and C-termini. The invention also encompasses pharmaceutical compositions containing these fusion molecules and methods for their use.
Another notable patent is "Compositions for increasing hematopoiesis with interleukin-3 mutants." This invention involves human interleukin-3 (hIL-3) variant or mutant proteins that are functionally co-administered with other colony stimulating factors, cytokines, lymphokines, interleukins, hematopoietic growth factors, or IL-3 variants. These compositions aim to enhance the process of hematopoiesis.
Career Highlights
Marie Helena Caparon has established herself as a leading figure in her field. Her innovative work has led to advancements in understanding and manipulating hematopoiesis, which is crucial for various medical applications.
Collaborations
Throughout her career, she has collaborated with notable professionals, including S Christopher Bauer and Mark Allen Abrams. These partnerships have contributed to the success and impact of her research.
Conclusion
Marie Helena Caparon's contributions to hematopoiesis research through her patented inventions highlight her role as a significant innovator in the field. Her work continues to influence advancements in medical science and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile